111 Inc (YI) Stock Analysis

$3.460

0.000 (0.00%)At close

Loading chart…

High: 3.460
Open: 3.600
VWAP: —
Vol: 0.00
Mkt Cap: 92.95M
Low: 3.460
Amount: 0.00
EV/EBITDA, TTM: 0.00

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market.

corporate.111.com.cn

Analyst Ratings (1)

Buy

1 Buy

0 Hold

0 Sell

Current: 3.46

Low

—

Average

—

High

—

See All Ratings

Valuation Metrics

The current forward P/E ratio for 111 Inc (YI) is 0.00, compared to its 5-year average forward P/E of 16.13.

Forward P/E

Fair

5Y Average P/E

16.13

Current P/E

0.00

Overvalued

65.66

Undervalued

-33.41

Forward EV/EBITDA

Fair

5Y Average EV/EBITDA

2.95

Current EV/EBITDA

0.00

Overvalued

26.77

Undervalued

-20.88

Forward P/S

Fair

5Y Average P/S

0.07

Current P/S

0.04

Overvalued

0.11

Undervalued

0.03

Events Timeline

2026-01-30 (ET)

14:50:00

111 Inc ADR Trading Halted Due to Volatility Trading Pause

2025-02-11 (ET)

07:01:56

111, Inc. regains Nasdaq compliance

2025-01-08 (ET)

04:08:32

111, Inc. announces one-for-twenty ADS ratio change

2024-10-10 (ET)

06:12:51

111, Inc. announces South, Central China fulfillment centers begin operations

2024-09-27 (ET)

17:28:47

111, Inc. discloses Nasdaq listing deficiency notice

Show More Events

News

YI FAQ — answered by Alphio AI

111 Inc is an investment holding company primarily engaged in the operation of integrated online and offline healthcare platform. The Company mainly operates its business through two segments. The Business to Customer (B2C) segment is engaged in the sale of pharmaceutical and other health and wellness products through 1 Medicine Marketplace, mobile apps, other online channels and offline pharmacies to consumers and certain enterprise customers. The Business to Business (B2B) segment is engaged in the sale of pharmaceutical products to pharmacies on 1 Pharmacy. The Company also provides customers with online consultation and electronic prescription services through the Internet hospital 1 Clinic. The Company’s products include drugs, nutritional supplements, medical supplies and devices and other products. The Company mainly conducts its business in the domestic market. It operates in the Healthcare sector (DRUG STORES AND PROPRIETARY STORES industry).

1 analysts cover YI: 1 rate it Buy, 0 Hold and 0 Sell.

This page is for research only and is not investment advice. Models can be wrong. Past performance does not guarantee future results.